Inflammatory cytokines are associated with the inflammatory state of myelodysplastic neoplasia, and it could be investigated whether the mutation in TET2 arises from inflammatory stresses. By conferring advantages, resistance to apoptosis in MDS becomes an avenue of investigation for therapeutic targets. This evidence concerns the gene TET2 and myelodysplastic syndrome.